BSEM•BioStem Technologies said it received a U.S. patent covering sterile human placental allografts and related manufacturing methods. Three additional U.S. patent applications and one Mexican application received notices of allowance.
BioStem Technologies reported a newly issued U.S. patent covering sterile human placental allografts and related manufacturing methods. Three additional U.S. patent applications received notices of allowance covering placental allografts, micronized umbilical cord combinations for wound care, and extracts for joint use; a Mexican application tied to the placental allograft technology also received a notice of allowance.
